Intressa Vascular
1 known investors
Find your way into Intressa Vascular
225 people in our graph share verified history with the Intressa Vascular team — schools, employers, funds. One of them is your warm intro.
Erin Mooreunlockedknows Pierre Douette · together at GlaxoSmithKline Biologicals (overlapped)
×7knows the team · via GlaxoSmithKline Biologicals
knows the team · via Eurogentec
knows the team · via Université de Liège
×2knows the team · via Université catholique de Louvain
Intressa Vascular develops the Allay Aortic Stent using proprietary multilayer braiding technology and personalized procedure planning to treat aortic dissections in patients requiring endovascular intervention.
Founders & leadership
PD
Pierre DouetteinChief Executive OfficerPierre Douette holds a PhD in Biochemistry and Master's degree in Management, with over 15 years of experience in medtech and biotech executive roles spanning medical device development, regulatory compliance, and clinical affairs for orthopedic, dermatologic, and cardiovascular innovations. He is Chief Executive Officer of Intressa Vascular, which develops aortic stent technology for endovascular treatment of aortic dissections.
Investors · 1
In the news
Frequently asked questions
- What does Intressa Vascular do?
- Intressa Vascular develops the Allay Aortic Stent using proprietary multilayer braiding technology and personalized procedure planning to treat aortic dissections in patients requiring endovascular intervention.
- Who are Intressa Vascular's investors?
- Intressa Vascular's investors include White Fund.